Change Country
Welcome to UK
Please read the important information below before continuing to our website

Please read the important information below before continuing to our website.  

By clicking on your client type to enter the website, you are confirming that you have read and understood the important information that is contained below, and you accept the terms of the Privacy and Cookies policy.

THIS WEBSITE IS AIMED AT PROFESSIONAL CLIENTS IN THE UK

The information on this website is published in the UK by Lyxor Asset Management UK LLP (Lyxor UK), which is authorized by Financial Conduct Authority in the UK, under FCA Registration Number 435658.

 

The website is hosted by on Microsoft Azure servers.

This website is subject to French law and English Law

 

A professional client is a client that is either a per se professional client or an elective professional client  (Note article 4 (1) 12 of Mifid )

 

A professional client is one of the following:

– an entity required to be authorised or regulated to operate in the financial markets. The following list includes all authorised entities carrying out the characteristic activities of the entities mentioned, whether authorised by an EEA State or a third country and whether or not authorised by reference to a directive:

  • a credit institution
  • an investment firm
  • any other authorised or regulated financial institution
  • an insurance company
  • a collective investment scheme or the management company of such a scheme
  • a pension fund or the management company of a pension fund
  • a commodity or commodity derivatives dealer
  • a local
  • any other institutional investor

– in relation to MiFID or equivalent third country business, a large undertaking, meeting two of the following size requirements on a company basis:

  • balance sheet total of EUR 20,000,000
  • net turnover of EUR 40,000,000
  • own funds of EUR 2,000,000

– in relation to business that is neither MiFID or equivalent third country business, a large undertaking meeting either of the following conditions:

  • a body corporate (including a limited liability partnership) which has (or any of whose holding companies or subsidiaries has) called up share capital of at least £10 million (or its equivalent in any other currency at the relevant time)
  • a large undertaking that meets (or any of whose holding companies or subsidiaries meets) two of the following tests: (i) a balance sheet total of EUR 12,500,000; (ii) a net turnover of EUR 25,000,000; (iii) an average number of employees during the year of 250
  • a national or regional government, a public body that manages public debt, a central bank, an international or supranational institution (such as the World Bank, the IMF, the ECP, the EIB) or another similar international organisation.
  • another institutional investor whose main activity is to invest in financial instruments (in relation to the firm's MiFID or equivalent third country business) or designated investments (in relation to the firm's other business). This includes entities dedicated to the securitisation of assets or other financing transactions.

 

The above definition is only an extract and is not exhaustive. For further details please refer to the Glossary section of the FSA Handbook: http://fsahandbook.info/FSA/html/handbook/Glossary/P

 

 

Lyxor and Lyxor ETF are names used by Lyxor Asset Management UK LLP to promote the products of Lyxor International Asset Management. Although information contained herein is from sources believed to be reliable, Lyxor Asset Management UK LLP makes no representation or warranty regarding the accuracy of any information. Any reproduction, disclosure or dissemination of these materials is prohibited.

 

Marketing Restrictions and Implications

 

Lyxor UCITS compliant Exchange Traded Funds (Lyxor UCITS ETFs) referred to on this website are open ended mutual investment funds (i) established under the French law and approved by the Autorité des Marchés Financiers (the French Financial Markets Authority), or (ii) established under the Luxembourg law and approved by the Commission de Surveillance du Secteur Financier (the Luxembourg Financial Supervisory Committee). Most, if not all, of the protections provided by the UK regulatory system generally and for UK authorised funds do not apply to these exchange traded funds (ETFs). In particular, investors should note that holdings in this product will not be covered by the provisions of the Financial Services Compensation Scheme, or by any similar scheme in France.

 

This website is exclusively intended for persons who are not "US persons", as such term is defined in Regulation S or the US Securities Act 1933, as amended, and who are not physically present in the US. This website does not constitute an offer or an invitation to purchase any securities in the United States or in any other jurisdiction in which such offer or invitation is not authorised or to any person to whom it is unlawful to make such offer or solicitation. Potential users of this website are requested to inform themselves about and to observe any such restrictions.

 

 

 

 

Index Replication Process

 

Lyxor UCITS ETFs follow both physical and synthetic index replication process.

 

However, most Lyxor UCITS ETFs follow synthetic replication process. This consists of entering into a derivative transaction (a ‘Performance Swap’, as defined below) with a counterparty that provides complete and effective exposure to its benchmark index. Lyxor has adopted this methodology in order to minimise tracking error, optimise transaction costs and reduce operational risks.

 

A Performance Swap is a contractual agreement which is negotiated over-the-counter (OTC) between two parties: the Lyxor UCITS ETF and its counterparty. From a risk perspective, each Performance Swap ranks equally with other senior unsecured obligations of the counterparty, such as common bonds (i.e., same rights to payments). In the Performance Swap, the counterparty of the Lyxor UCITS ETF commits to pay the Lyxor UCITS ETF a variable return based on a pre-determined benchmark index, instead of a fixed stream of income (as in bonds). At the same time, the counterparty will receive from the Lyxor UCITS ETF the performance and any related revenues generated by the basket's assets (excluding the value of the Performance Swap) held by the Lyxor UCITS ETF. Information provided on individual ETFs includes data on the basket relating to the ETF and the percentage value of the basket represented by each asset. The information is relevant to the closing values on the date given. 

 

Investment Risks

 

The Lyxor UCITS ETFs described on this website are not suitable for everyone. Investors' capital is at risk. Investors should not deal in this product unless they understand, having obtained independent professional advice where necessary, its nature, terms and conditions, and the extent of their exposure to risk. The value of the product can go down as well as up and can be subject to volatility due to factors such as price changes in the underlying instrument and interest rates. If a fund is quoted in a different currency to the index, currency risks exist.

 

Prior to any investment in any Lyxor UCITS ETF, you should make your own appraisal of the risks from a financial, legal and tax perspective, without relying exclusively on the information provided by us. We recommend that you consult your own independent professional advisors (including legal, tax, financial or accounting advisors, as appropriate).

 

Specific Risks

 

·         Capital at Risk. ETFs are tracking instruments: Their risk profile is similar to a direct investment in the Benchmark Index. Investors’ capital is fully at risk and investors may not get back the amount originally invested. Investments are not covered by the provisions of the Financial Services Compensation Scheme (“FSCS”), or any similar scheme.

·         Counterparty Risk. Investors may be exposed to risks resulting from the use of an OTC Swap with Societe Generale. Physical ETFs may have Counterparty Risk resulting from the use of a Securities Lending Programme.

·         Currency Risk. ETFs may be exposed to currency risk if the ETF or Benchmark Index holdings are denominated in a currency different to that of the Benchmark Index they are tracking. This means that exchange rate fluctuations could have a negative or positive effect on returns.

·         Replication Risk. ETFs are designed to replicate the performance of the Benchmark Index. Unexpected events relating to the constituents of the Benchmark Index may impact the Index provider’s ability to calculate the Benchmark Index, which may affect the ETF’s ability to replicate the Benchmark Index efficiently. This may create Tracking Error in the ETF.

·         Underlying Risk. The Benchmark Index of a Lyxor ETF may be complex and volatile. When investing in commodities, the Benchmark Index is calculated with reference to commodity futures contracts which can expose investors to risks related to the cost of carry and transportation. ETFs exposed to Emerging Markets carry a greater risk of potential loss than investment in Developed Markets as they are exposed to a wide range of unpredictable Emerging Market risks.

·         Liquidity Risk. On-exchange liquidity may be limited as a result of a suspension in the underlying market represented by the Benchmark Index tracked by the ETF; a failure in the systems of one of the relevant stock exchanges, Societe Generale or other Market Maker systems; or an abnormal trading situation or event.

 

The securities can be neither offered in nor transferred to the United States.

 

Tax

 

Any statement in relation to tax, where made, is generic and non-exhaustive and is based on our understanding of the laws and practice in force as of the date of this document and is subject to any changes in law and practice and the interpretation and application thereof, which changes could be made with retroactive effect. Any such statement must not be construed as tax advice and must not be relied upon. The tax treatment of investments will, inter alia, depend on an individual’s circumstances. Investors must consult with an appropriate professional tax adviser to ascertain for themselves the taxation consequences of acquiring, holding and/or disposing of any investments mentioned on this website. 

 

Further information on the risk factors are available in the [Risk Warning – link to risk page] section of the website.

 

Any fund prospectus and supplements are available at www.lyxoretf.co.uk. Information given about the past performance of the funds is no guarantee of future performance. No investment decision should be taken without reading the fund prospectus and the key information document available of the fund concerned.

 

Although the content of the website is based upon information that Lyxor UK consider reliable or comes from sources that Lyxor UK consider reliable, Lyxor UK has not verified such information. Lyxor UK make no representation or warranty as to the accuracy, completeness or adequacy of any information.  Any reproduction, disclosure or dissemination of the materials available on the website is prohibited.

 

Cookies

This website uses cookies to make the website work or improve your user experience. Cookies are small text files that are saved on your computer or device, which are used for several purposes such as detecting preferences and improving site navigation. By continuing to use this website you consent for cookies to be used. For more details, including how to amend your preferences, please read our [Cookies Policy] link to privacy & cookie page.

By clicking on your client type to enter the website, you shall be deemed to have represented to us that you are not a U.S. person and that you are not located in the United States of America, its territories and possessions, and any State of the United States of America and that you are authorised to receive the information to and on this website.

 

 

I CONFIRM THAT I HAVE READ AND UNDERSTOOD THE IMPORTANT INFORMATION THAT IS CONTAINED ABOVE AND ACCEPT THE TERMS OF THE PRIVACY AND COOKIES POLICY.

By continuing to browse the site, you are agree on the use of cookies to track the number of visits.To know more about cookies policy:click here
18 Jun 2018

4 things to do in Q3


chan

By Chanchal Samadder, Head of Equity ETF

Around now, thoughts tend to turn to the holidays and long, relaxing days by the beach. But before reaching for the suncream you have to check the forecasts and ensure your portfolio also has the requisite protection. Like an unruly child running by the pool, or an English central defender dwelling on the ball, today’s markets and politics demand constant attention. Here’s our guide to a successful and stress-free summer:

1. Be prepared for bad weather


We advise caution currently given trade wars, geopolitical tensions, rising populism and the omnipresent uncertainly over the timing and/or extent of the withdrawal from ‘super loose’ monetary policies. We expect some stormy conditions – especially among equities – as the cost of debt spirals and the global economy peaks. Decent returns will be harder to find, especially in more mainstream destinations, so for peace of mind we’re focusing on diversifying by getting off the beaten track and using risk reducers and other protection strategies.


ETFs to consider 

Fund name  Bloomberg ticker  Index ticker  TER Asset class
Lyxor FTSE USA Minimum Variance MVAU

WIUSAMVN

0.20%

Equities

Lyxor FTSE Europe Minimum Variance 

MVAE

AWDEUMVN

0.20%

Equities

Lyxor FTSE US Quality Low Vol Dividend 

BUCK

FUSYQVCN

0.19%

Equities

Lyxor FTSE UK Quality Low Vol Dividend 

DOSH

FNMIQV5T

0.19%

Equities

Lyxor SG Global Quality Income NTR

SGQI

SGQINTR

0.45%

Equities

Source: Lyxor International Asset Management, TER as a 13 June 2018 

2. Choose your destination wisely

There are some bright spots however, so we’re not entirely risk-averse. Europe’s busy political agenda could delay policy tightening, and the current soft patch is temporary in our eyes. Any rebound should trigger a catch-up of earnings growth and support stocks. For now though, political issues ensure we’re not as positive as we once were but France looks attractive on the back of strong structural reforms. We continue to favour cyclical sectors such as consumer discretionary as well as construction and materials. They are well positioned to benefit from the domestic recovery and have been deleveraging and improving their solvency in the last couple of years. We’re steering clear of most conventional European bonds.


Euro area earnings catching up

12-month trailing EPS for MSCI Indices


                  Chart 1

THE FIGURES RELATING TO PAST PERFORMANCES REFER TO PAST PERIODS AND ARE NOT A RELIABLE INDICATOR FOR FUTURE RESULTS. THIS ALSO APPLIES TO HISTORICAL MARKET DATA.
Sources:  Lyxor International AM, Bloomberg, Citigroup, SG Cross-Asset Research/Global Asset Allocation/ Equity Strategy as at 13/06/2018

In the US, the headwinds are such that they should keep the Fed tied to its current path. We expect Treasuries to remain de-coupled from political tensions in Europe and to gradually drift higher from here. We expect lower returns from equities, especially as there’s little room for additional economic impetus beyond the tax cuts and the mid-term elections threaten some turbulence. Corporate buying should at least provide some support. Credit (whether high or low quality) is off our radar as the cost of debt is rising at a time when leverage is at all-time highs and recession may be drawing closer.

We remain positive on commodities, but prefer base metals. Both oil and base metals should continue to be supported by strong fundamentals as recovering demand meets with struggling supply. Oil comes with a little more downside risk however. We’re also interested in those commodity-linked assets, like the FTSE 100, which lagged the initial commodity price recovery. 


Commodities’ performance at different stages of the economic cycle*

                     Chart 2

*Different stages of the economic cycle determined through the shape of US yield curve. Analysis since January 2000. Average performance of assets for each period. THE FIGURES RELATING TO PAST PERFORMANCES REFER TO PAST PERIODS AND ARE NOT A RELIABLE INDICATOR FOR FUTURE RESULTS. THIS ALSO APPLIES TO HISTORICAL MARKET DATA.Sources:  Lyxor International AM, Bloomberg, SG Cross-Asset Research/Global Asset Allocation/ Equity Strategy as at 13/06/2018

Inflation as an asset class remains of interest, and breakevens may represent the path of least resistance over the coming months. They also offer diversification benefits which could prove beneficial as we head for the exit from a low inflation, low volatility world.  


ETFs to consider 

Fund name  Bloomberg ticker  Index ticker  TER Asset Class
Lyxor CAC 40  CAC

CACR

0.25%

Equities

Lyxor MSCI EMU Small Cap  MMS

M7EMSC

0.40%

Equities

Lyxor Commodities Thomson Reuters/ CoreCommodity CRB  CRB

CRYTR

0.35%

Commodities

Lyxor MSCI World Energy TR  NRGW

NDWUENR

0.30%

Equities

Lyxor US$ 10Y Inflation Expectations  INFU

IBXXUBF1

0.25%

Fixed income

Source: Lyxor International Asset Management, TER as a 13 June 2018 


3. Consider something more exotic

​​

With developed markets overcrowded and overvalued, it could be time to spread your wings to some more exotic destinations. We like China, but it could be time to include a few more emerging markets in your plans. A number of other countries offer external surpluses, low inflation and reasonable growth and could now be better value after the recent sell-off. This should provide protection when the greenback’s run of strength eventually gives way. It could be time to renew your focus on Asia’s domestic stories given external risks might rising. Onshore Chinese equities benefit from reasonable growth, increased accessibility and low correlation with developed equities. ASEAN markets also appeal as could, in time, India. 

ETFs to consider 

Fund name Bloomberg ticker  Index ticker  TER Asset class
Lyxor China Enterprise (HSCEI) 

ASI

HSI21N

0.65%

Equities

Lyxor MSCI India 

INR

NDEUSIA

0.85%

Equities

Lyxor MSCI Indonesia

INDO

M0ID

0.55%

Equities

Lyxor MSCI Malaysia 

MAL

NDDUMAF

0.65%

Equities

Lyxor Thailand 

THA

SET50NTR

0.45%

Equities

Source: Lyxor International Asset Management, TER as a 13 June 2018 



4. Travel only in good company 

​​

The US economy has been more resilient than its counterparts in Japan and the eurozone. However, its economic surprise indicator has already passed its peak. Corporate bonds should come under pressure as corporate debt piles up - further encouraged by fiscal reform - and the Fed tightens. If you do have to hold credit, we’d suggest making any journey brief. When debt fears rise and balance sheets come under the microscope, equity volatility also tends to increase, providing an incentive to reduce or reshape your equity exposures. A greater weighting to quality income or value stocks could be a solution at this late stage of the cycle.

At this stage, credit spreads have remained quiet

               Chart 3


THE FIGURES RELATING TO PAST PERFORMANCES REFER TO PAST PERIODS AND ARE NOT A RELIABLE INDICATOR FOR FUTURE RESULTS. THIS ALSO APPLIES TO HISTORICAL MARKET DATA. Sources:  Lyxor International AM, Bloomberg, BEA, SG Cross-Asset Research/Global Asset Allocation/ Economics as at 13/06/2018

 ETFs to consider 

Fund name 

Bloomberg Ticker

Index Ticker

TER

Asset class

Lyxor FTSE US Quality Low Vol Dividend 

BUCK

FUSYQVCN

0.19%

Equities

Lyxor Russell 1000 Value 

RUSV

RU1VN30U

0.19%

Equities

Lyxor SG Global Value Beta 

SGVB

SGVBNTR

0.40%

Equities

Lyxor MSCI EMU Value 

VAL

M7EM000V

0.40%

Equities

All views & opinion: Lyxor Equity ETF & Lyxor Cross Asset Research teams, as at 13 June 2018. Charts sourced from SG Cross Asset Research team (“Expect less for longer”). Past performance is no guide to future returns. *All TERs correct as at 13 June 2018.

Risk Warning


THIS COMMUNICATION IS FOR ELIGIBLE COUNTERPARTIES OR PROFESSIONAL CLIENTS ONLY

Past performance is no guide to future returns.

This document is for the exclusive use of investors acting on their own account and categorized either as “Eligible Counterparties” or “Professional Clients” within the meaning of Markets in Financial Instruments Directive 2004/39/EC. These products comply with the UCITS Directive (2009/65/EC). Société Générale and Lyxor International Asset Management (LIAM) recommend that investors read carefully the “investment risks” section of the product’s documentation (prospectus and KIID). The prospectus and KIID are available free of charge on www.lyxoretf.com, and upon request to client-services-etf@lyxor.com.

The products mentioned are the object of market-making contracts, the purpose of which is to ensure the liquidity of the products on the London Stock Exchange, assuming normal market conditions and normally functioning computer systems. Units of a specific UCITS ETF managed by an asset manager and purchased on the secondary market cannot usually be sold directly back to the asset manager itself. Investors must buy and sell units on a secondary market with the assistance of an intermediary (e.g. a stockbroker) and may incur fees for doing so. In addition, investors may pay more than the current net asset value when buying units and may receive less than the current net asset value when selling them. Updated composition of the product’s investment portfolio is available on www.lyxoretf.com. In addition, the indicative net asset value is published on the Reuters and Bloomberg pages of the product, and might also be mentioned on the websites of the stock exchanges where the product is listed.

Prior to investing in the product, investors should seek independent financial, tax, accounting and legal advice. It is each investor’s responsibility to ascertain that it is authorised to subscribe, or invest into this product. This document is of a commercial nature and not of a regulatory nature. This material is of a commercial nature and not a regulatory nature. This document does not constitute an offer, or an invitation to make an offer, from Société Générale, Lyxor Asset Management (together with its affiliates, Lyxor AM) or any of their respective subsidiaries to purchase or sell the product referred to herein.

Lyxor International Asset Management (LIAM), société par actions simplifiée having its registered office at Tours Société Générale, 17 cours Valmy, 92800 Puteaux (France), 418 862 215 RCS Nanterre, is authorized and regulated by the Autorité des Marchés Financiers (AMF) under the UCITS Directive (2009/65/EU) and the AIFM Directive (2011/31/EU). LIAM is represented in the UK by Lyxor Asset Management UK LLP, which is authorized and regulated by the Financial Conduct Authority in the UK under Registration Number 435658. Société Générale is a French credit institution (bank) authorised by the Autorité de contrôle prudentiel et de résolution (the French Prudential Control Authority).

Research disclaimer

Lyxor International Asset Management (“LIAM”) or its employees may have or maintain business relationships with companies covered in its research reports. As a result, investors should be aware that LIAM and its employees may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Please see appendix at the end of this report for the analyst(s) certification(s), important disclosures and disclaimers. Alternatively, visit our global research disclosure website www.lyxoretf.com/compliance.

Conflicts of interest 

This research contains the views, opinions and recommendations of Lyxor International Asset Management (“LIAM”) Cross Asset and ETF research analysts and/or strategists. To the extent that this research contains trade ideas based on macro views of economic market conditions or relative value, it may differ from the fundamental Cross Asset and ETF Research opinions and recommendations contained in Cross Asset and ETF Research sector or company research reports and from the views and opinions of other departments of LIAM and its affiliates. Lyxor Cross Asset and ETF research analysts and/or strategists routinely consult with LIAM sales and portfolio management personnel regarding market information including, but not limited to, pricing, spread levels and trading activity of ETFs tracking equity, fixed income and commodity indices. Trading desks may trade, or have traded, as principal on the basis of the research analyst(s) views and reports. Lyxor has mandatory research policies and procedures that are reasonably designed to (i) ensure that purported facts in research reports are based on reliable information and (ii) to prevent improper selective or tiered dissemination of research reports. In addition, research analysts receive compensation based, in part, on the quality and accuracy of their analysis, client feedback, competitive factors and LIAM’s total revenues including revenues from management fees and investment advisory fees and distribution fees.

Connect with us on linkedin